3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Medullary
1
Interventions
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
belzutifan
1
Lutetium-177
1
Lutetium
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Paraganglioma
×
vandetanib
×
Clear all
No trials found.